Julie Warner: A regulatory roadmap to translation of ATMPs

Dr Julie Warner, Vice President of Regulatory Affairs, will be taking part in the ‘From Concept to Clinic’ event hosted by Medcity and the South West Advanced Therapies Network (SWATN) on the 11th May 2022. 

Julie will be talking about the regulatory landscape for advanced therapies to over 1000 members. The hybrid event, held at Science Creates new Bristol Incubator, will bring together industry, clinicians and academics involved in advanced therapies.

Julie is Vice President of Regulatory Affairs at Boyds and is experienced in regulations of cell and gene therapies covering the early research work through to product approval and beyond. She is also well known for her expertise through working with the MHRA, other EU regulators, the EMA and the FDA on behalf of Boyds clients.

To find out more click here.